Literature DB >> 580345

Cardio-respiratory toxicity of propoxyphene and norpropoxyphene in conscious rabbits.

H Lund-Jacobsen.   

Abstract

The toxic effects of alpha-d-propoxyphene (P) and its primary metabolite alpha-d-norpropoxyphene (NP) were compared to intravenous infusions (100 min.) of equimolar doses of P and NP (80 micronmol/kg equivalent to 30 mg/kg P HCl) in conscious rabbits. During P infusion severe respiratory depression and convulsions were seen in all animals, and six of the nine animals died. During NP infusion, however, only minimal respiratory depression was seen and all the animals survived. Considerable prolongation of the QRS complex and cardiac arrhythmias like intermittent A-V block and ventricular extrasystoles were seen in the ECG during both P and NP infusion, while the arterial blood pressure was unchanged. In P injection experiments (6 mg/kg P HCl), ECG changes preceded reduction in respiratory rate and during NP infusion only minor changes were seen in arterial blood gases, demonstrating that the ECG changes produced by P and NP are independent of respiratory depression. The ECG changes were found to be similar to those reported in quinidine intoxication. The QRS prolongation was markedly correlated with plasma concentrations during and after P and NP infusion. The results of the present investigation favour the hypothesis that the contribution of NP to the toxicity of oral P overdosage in man is ascribed to its cardiotoxic action whereas P is responsible for the CNS toxicity (respiratory depression and convulsions) as well as cardiotoxicity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 580345     DOI: 10.1111/j.1600-0773.1978.tb02187.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


  10 in total

Review 1.  Acute poisoning: understanding 90% of cases in a nutshell.

Authors:  S L Greene; P I Dargan; A L Jones
Journal:  Postgrad Med J       Date:  2005-04       Impact factor: 2.401

Review 2.  Pharmacokinetics of opioids in liver disease.

Authors:  I Tegeder; J Lötsch; G Geisslinger
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

3.  D-propoxyphene kinetics in man: significance of a deep third compartment.

Authors:  L F Gram; K Schmidt; F N Christensen; J Schou
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 4.  Drug metabolites in renal failure: pharmacokinetic and clinical implications.

Authors:  R K Verbeeck; R A Branch; G R Wilkinson
Journal:  Clin Pharmacokinet       Date:  1981 Sep-Oct       Impact factor: 6.447

Review 5.  Dextropropoxyphene overdose. Epidemiology, clinical presentation and management.

Authors:  A A Lawson; D B Northridge
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Nov-Dec

6.  Marked QRS complex abnormalities and sodium channel blockade by propoxyphene reversed with lidocaine.

Authors:  D C Whitcomb; F R Gilliam; C F Starmer; A O Grant
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

7.  Dextropropoxyphene kinetics after single and repeated oral doses in man.

Authors:  K Brøsen; L F Gram; J Schou; N E Larsen; P Thayssen
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

8.  Lack of evidence of increased lethality due to propoxyphene overdose in the presence of ethanol in male Wistar rats.

Authors:  E Bodd; H Olsen; M Gulliksen; J Mørland
Journal:  Arch Toxicol       Date:  1985-01       Impact factor: 5.153

Review 9.  Dextropropoxyphene overdosage. Pharmacological considerations and clinical management.

Authors:  R J Young
Journal:  Drugs       Date:  1983-07       Impact factor: 9.546

Review 10.  Clinical review: Drug metabolism and nonrenal clearance in acute kidney injury.

Authors:  A Mary Vilay; Mariann D Churchwell; Bruce A Mueller
Journal:  Crit Care       Date:  2008-11-12       Impact factor: 9.097

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.